The $200K Challenge brings together many of the brightest life sciences startups to pitch their innovations for a chance to win $200K of in-kind services. One of this year’s 15 finalists is Oriel Research Therapeutics, whose goal is to identify sepsis at its early stage, before it becomes very challenging to treat and in many cases irreversible.
We talked with Eila Arich-Landkof, founder of Oriel Research Therapeutics, to learn more about her personal inspiration that led them to the $200K Challenge.
Continue reading
